Category:Michael J. TORRES of Irving TX (US)

Michael J. TORRES of Irving TX (US)

Executive Summary

Michael J. TORRES of Irving TX (US) is an inventor who has filed 1 patents. Their primary areas of innovation include PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (1 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (1 patents), and they have worked with companies such as The Board of Regents of The University of Texas System (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

File:Michael J. TORRES of Irving TX (US) Monthly Patent Applications.png

Technology Areas

File:Michael J. TORRES of Irving TX (US) Top Technology Areas.png

List of Technology Areas

• A61K9/5123 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K48/0033 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 1 patents
• C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 1 patents
• C12N15/111 ({General methods applicable to biologically active non-coding nucleic acids}): 1 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
• C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2320/32 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

File:Michael J. TORRES of Irving TX (US) Top Companies.png

List of Companies

• The Board of Regents of The University of Texas System: 1 patents

Collaborators

• Daniel J. SIEGWART of Dallas TX (US) (1 collaborations)
• Philip J. THOMAS of Dallas TX (US) (1 collaborations)
• Arthur E. JOHNSON of Florence NJ (US) (1 collaborations)
• Jason B. MILLER of Dallas TX (US) (1 collaborations)